01 1Suven Life Sciences Limited
01 1ENTACAPONE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-04-15
Pay. Date : 2019-02-19
DMF Number : 33330
Submission : 2018-12-13
Status : Active
Type : II
20
Suven Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is ENTACAPONE USP, with a corresponding US DMF Number 33330.
Remarkably, this DMF maintains an Active status since its submission on December 13, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 15, 2019, and payment made on February 19, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
